Sidebar: Obesity: Three New Drug Candidates Promise A New Dawn
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Arena is positioning its pending anti-obesity NME lorcaserin as the cure for the obesity market hangover induced by the troublesome side effect profiles associated with earlier Rx weight loss products.